Conducting Clinical Trials Outside the U.S.: U.S. and Foreign Rules, Regulations, and Guidance
Navigating FDA Requirements, HIPAA, FCPA, Export Controls, Economic Sanctions, Data Protection Laws, and Other Types of Foreign Laws Researchers May Encounter
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will guide life sciences companies and research institutions that are conducting or considering conducting clinical trials outside the U.S. The panel will discuss the benefits and barriers and address the U.S. and foreign rules and regulations that must be kept in mind. The panel will offer guidance for those considering clinical trials outside the U.S.
Outline
- Conducting clinical trials outside the U.S.
- Trends in globalization of clinical trials
- Benefits and drawbacks of conducting research abroad, for both industry and academia
- What can go wrong
- Applicable laws
- U.S. research laws
- FDA
- Common Rule
- HIPAA
- Federal grant requirements
- Foreign laws
- Research and related laws
- Data protection laws
- U.S. laws of general applicability
- FCPA
- Export control
- Sanctions
- U.S. research laws
- Practical and operational considerations/best practices
Benefits
The panel will review these and other key issues:
- What laws apply to privately and federally funded research sponsored by U.S. organizations and conducted overseas?
- How can U.S. organizations ensure that data from foreign clinical trials is collected in such a way that it can be used as intended?
- What are best practices to mitigate risk and help ensure project success in foreign clinical trials?
Faculty
Clint D. Hermes
Counsel
Bass Berry & Sims
Clint Hermes draws on his experience as Chief Legal Officer of two research institutions to advise clients on all... | Read More
Clint Hermes draws on his experience as Chief Legal Officer of two research institutions to advise clients on all regulatory and contracting aspects of human and animal research. His work on behalf of the research missions of academic medical centers and life sciences companies has taken him throughout Africa, Asia, the Middle East, and South America.
CloseThaddeus R. McBride
Member
Bass Berry & Sims
Mr. McBride represents companies and individuals in international trade regulatory, compliance, investigative, and... | Read More
Mr. McBride represents companies and individuals in international trade regulatory, compliance, investigative, and enforcement matters involving U.S. economic sanctions and economic embargoes, U.S. export controls, FCPA, U.S. anti-boycott controls, U.S. customs and other import controls, anti-money laundering and other banking controls, and U.S. international trade enforcement and regulatory actions.
CloseRoy Wyman
Member
Bass Berry & Sims
For nearly 30 years, Mr. Wyman has represented a variety of commercial entities on complex data privacy and security... | Read More
For nearly 30 years, Mr. Wyman has represented a variety of commercial entities on complex data privacy and security matters and related regulatory concerns. He counsels in-house legal departments, c-suites, boards of directors and IT teams as they navigate data privacy and cybersecurity issues arising under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), General Data Protection Regulation (EU GDPR), Telephone Consumer Protection Act (TCPA), CAN-SPAM Act, state privacy laws like California Privacy Rights Act (CPRA) and other related statutes.
Close